It's time to end the stigma

  • Home
  • About Us
    • About Us
    • Join Us
    • ACNA welcome from AMCA
    • Affiliated Organisations
    • MC Awareness Week
  • Nurses
    • Resources for Nurses
    • News & Updates
    • UIC Symposium 2023
    • Drive Change
    • AMCA Interest Groups
    • Offers for ACNA members
    • AMCA Submissions
  • Patients
    • Recommended Resources
    • Patient Stories
    • Compassionate Access
    • International Pain Survey
  • Contact Us
  • More
    • Home
    • About Us
      • About Us
      • Join Us
      • ACNA welcome from AMCA
      • Affiliated Organisations
      • MC Awareness Week
    • Nurses
      • Resources for Nurses
      • News & Updates
      • UIC Symposium 2023
      • Drive Change
      • AMCA Interest Groups
      • Offers for ACNA members
      • AMCA Submissions
    • Patients
      • Recommended Resources
      • Patient Stories
      • Compassionate Access
      • International Pain Survey
    • Contact Us
  • Home
  • About Us
    • About Us
    • Join Us
    • ACNA welcome from AMCA
    • Affiliated Organisations
    • MC Awareness Week
  • Nurses
    • Resources for Nurses
    • News & Updates
    • UIC Symposium 2023
    • Drive Change
    • AMCA Interest Groups
    • Offers for ACNA members
    • AMCA Submissions
  • Patients
    • Recommended Resources
    • Patient Stories
    • Compassionate Access
    • International Pain Survey
  • Contact Us

Drive Change: Sign the Petition

Drive Change

Drive Change

Meet The Cannabis Law Reform Alliance


A team of educators and advocates have joined forces to be the voice for cannabis law reform Australia-wide.


The CLRA’s first campaign is Drive Change.

Article: Cannabis Related Impairment Framework

Download PDF

new study from the University of Sydney’s Lambert Initiative

Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis


 

Highlights:


  • THC-related biomarkers were associated with impairment in occasional cannabis users.


  • However, most of these ‘biomarker–performance’ relationships were ‘weak’ in strength.


  • THC-related biomarkers were not associated with impairment in regular cannabis users.


  • THC-related biomarkers are relatively poor indicators of cannabis-induced impairment.

Published in Neuroscience & Biobehavioral Reviews

Click here to access online

International JOURNAL OF DRUG POLICY (Volume 97, Nov 2021)

Medicinal cannabis and driving: the intersection of health and road safety policy

Background

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. However, the positioning of cannabis as a legitimate medical product produces some tensions with other regulatory frameworks. A notable example of this is the so-called ‘zero tolerance’ drug driving legal frameworks, which criminalise the presence of THC (tetrahydrocannabinol) in a driver's bodily fluids irrespective of impairment. Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia.


Conclusion

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects.


Click picture to see full abstract

  • Home
  • Join Us
  • Contact Us

Australian Cannabis Nurses Association

COPYRIGHT © 2023 AUSTRALIAN CANNABIS NURSES ASSOCIATION | AUSTRALIAN MEDICAL CANNABIS ASSOCIATION LIMITED - ALL RIGHTS RESERVED.

 

We acknowledge and honour the traditional custodians of our land, the Aboriginal & Torres Strait Islander people. 

We acknowledge them as a proud culture and peoples with deep wisdom and great knowledge about our land. 

We pay our respects to Aboriginal & Torres Straight Islander elders: past, present & emerging

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept